Literature DB >> 21296860

Batf promotes growth arrest and terminal differentiation of mouse myeloid leukemia cells.

Juan Liao1, Sean E Humphrey, Stacie Poston, Elizabeth J Taparowsky.   

Abstract

Batf is a basic leucine zipper transcription factor belonging to the activator protein-1 superfamily. Batf expression is regulated following stimulation of both lymphoid and myeloid cells. When treated with leukemia inhibitory factor, mouse M1 myeloid leukemia cells commit to a macrophage differentiation program that is dependent on Stat3 and involves the induction of Batf gene transcription via the binding of Stat3 to the Batf promoter. RNA interference was employed to block Batf induction in this system and the cells failed to growth arrest or to terminally differentiate. Restoring Batf expression not only reversed the differentiation-defective phenotype but also caused the cells to display signs of spontaneous differentiation in the absence of stimulation. Efforts to define genetic targets of the Batf transcription factor in M1 cells led to the identification of c-myb, a proto-oncogene known to promote blood cell proliferation and to inhibit the differentiation of M1 cells. These results provide strong evidence that Batf mediates the differentiation-inducing effects of Stat3 signaling in M1 cells and suggest that Batf may play a similar role in other blood cell lineages where alterations to the Jak-Stat pathway are hallmarks of disrupted development and disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21296860      PMCID: PMC3060294          DOI: 10.1158/1541-7786.MCR-10-0375

Source DB:  PubMed          Journal:  Mol Cancer Res        ISSN: 1541-7786            Impact factor:   5.852


  47 in total

Review 1.  AP-1 subunits: quarrel and harmony among siblings.

Authors:  Jochen Hess; Peter Angel; Marina Schorpp-Kistner
Journal:  J Cell Sci       Date:  2004-12-01       Impact factor: 5.285

2.  Genomic organization of human B-ATF, a target for regulation by EBV and HTLV-1.

Authors:  N P Meyer; L M Johansen; H J Tae; P P Budde; K L Williams; E J Taparowsky
Journal:  Mamm Genome       Date:  1998-10       Impact factor: 2.957

Review 3.  MyD genes in negative growth control.

Authors:  D A Liebermann; B Hoffman
Journal:  Oncogene       Date:  1998-12-24       Impact factor: 9.867

Review 4.  Gp130 and the interleukin-6 family of cytokines.

Authors:  T Taga; T Kishimoto
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

5.  The zinc finger transcription factor Egr-1 activates macrophage differentiation in M1 myeloblastic leukemia cells.

Authors:  K Krishnaraju; B Hoffman; D A Liebermann
Journal:  Blood       Date:  1998-09-15       Impact factor: 22.113

6.  Egr-1 abrogates the block imparted by c-Myc on terminal M1 myeloid differentiation.

Authors:  Marianna Shafarenko; Dan A Liebermann; Barbara Hoffman
Journal:  Blood       Date:  2005-04-19       Impact factor: 22.113

7.  c-Myb is critical for B cell development and maintenance of follicular B cells.

Authors:  Matthew D Thomas; Christopher S Kremer; Kodi S Ravichandran; Klaus Rajewsky; Timothy P Bender
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

8.  A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells.

Authors:  K Nakajima; Y Yamanaka; K Nakae; H Kojima; M Ichiba; N Kiuchi; T Kitaoka; T Fukada; M Hibi; T Hirano
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

9.  Direct manipulation of activator protein-1 controls thymocyte proliferation in vitro.

Authors:  Tina M Thornton; Alfred J Zullo; Kristi L Williams; Elizabeth J Taparowsky
Journal:  Eur J Immunol       Date:  2006-01       Impact factor: 5.532

10.  cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.

Authors:  M Suhasini; C D Reddy; E P Reddy; J A DiDonato; R B Pilz
Journal:  Oncogene       Date:  1997-10-09       Impact factor: 9.867

View more
  17 in total

1.  Th9 cell development requires a BATF-regulated transcriptional network.

Authors:  Rukhsana Jabeen; Ritobrata Goswami; Olufolakemi Awe; Aishwarya Kulkarni; Evelyn T Nguyen; Andrea Attenasio; Daniel Walsh; Matthew R Olson; Myung H Kim; Robert S Tepper; Jie Sun; Chang H Kim; Elizabeth J Taparowsky; Baohua Zhou; Mark H Kaplan
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

2.  Increased BATF expression is associated with the severity of liver damage in patients with chronic hepatitis B.

Authors:  Li-Yuan Wang; Yu-Chen Fan; Jing Zhao; Xiang-Fen Ji; Kai Wang
Journal:  Clin Exp Med       Date:  2017-11-21       Impact factor: 3.984

3.  BATF regulates the expression of Nfil3, Wnt10a and miR155hg for efficient induction of antibody class switch recombination in mice.

Authors:  Rosemary E Morman; Patrick G Schweickert; Stephen F Konieczny; Elizabeth J Taparowsky
Journal:  Eur J Immunol       Date:  2018-06-26       Impact factor: 5.532

4.  Role of UTX in retinoic acid receptor-mediated gene regulation in leukemia.

Authors:  Luciana Rocha-Viegas; Raffaella Villa; Arantxa Gutierrez; Oihana Iriondo; Ramin Shiekhattar; Luciano Di Croce
Journal:  Mol Cell Biol       Date:  2014-07-28       Impact factor: 4.272

5.  Overexpression of Batf induces an apoptotic defect and an associated lymphoproliferative disorder in mice.

Authors:  M R Logan; K L Jordan-Williams; S Poston; J Liao; E J Taparowsky
Journal:  Cell Death Dis       Date:  2012-05-17       Impact factor: 8.469

6.  Identifying module biomarker in type 2 diabetes mellitus by discriminative area of functional activity.

Authors:  Xindong Zhang; Lin Gao; Zhi-Ping Liu; Luonan Chen
Journal:  BMC Bioinformatics       Date:  2015-03-18       Impact factor: 3.169

7.  BATF regulates the development and function of IL-17 producing iNKT cells.

Authors:  Kimberly L Jordan-Williams; Stacie Poston; Elizabeth J Taparowsky
Journal:  BMC Immunol       Date:  2013-03-27       Impact factor: 3.615

8.  STAT3 targets suggest mechanisms of aggressive tumorigenesis in diffuse large B-cell lymphoma.

Authors:  Jennifer Hardee; Zhengqing Ouyang; Yuping Zhang; Anshul Kundaje; Philippe Lacroute; Michael Snyder
Journal:  G3 (Bethesda)       Date:  2013-12-09       Impact factor: 3.154

9.  Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.

Authors:  Ljubov Balabko; Katerina Andreev; Nadine Burmann; Melanie Schubert; Martina Mathews; Denis I Trufa; Sarah Reppert; Tilmann Rau; Martin Schicht; Horia Sirbu; Arndt Hartmann; Susetta Finotto
Journal:  Sci Rep       Date:  2014-12-10       Impact factor: 4.379

10.  Engagement of CD99 Reduces AP-1 Activity by Inducing BATF in the Human Multiple Myeloma Cell Line RPMI8226.

Authors:  Minchan Gil; Hyo-Kyung Pak; Seo-Jeong Park; A-Neum Lee; Young-Soo Park; Hyangsin Lee; Hyunji Lee; Kyung-Eun Kim; Kyung Jin Lee; Dok Hyun Yoon; Yoo-Sam Chung; Chan-Sik Park
Journal:  Immune Netw       Date:  2015-10-26       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.